yttrium-90-radioembolization - Sorry! Your Search Result Empty

I am a Prostate Cancer patient from USA (name withheld on request). I came to India, specifically to the Department of Nuclear Medicine & Molecular Im

Transarterial Chemoembolisation or TACE has been the initial treatment modality for HCC and has a huge body of evidence from several studies and clini

Yttrium-90 or Y90is a commonly used isotope in the medical field specially in departments like nuclear medicine and radiation oncology for radiation t

This overview provides the patient and the caregiver a peek at what to expect during a typical PRRT treatment with Lu177 (Lutathera) and it covers the

PRRT or Peptide Receptor Radionuclide Therapy is a type of Nuclear Medicine Therapy in which a cell-targeting protein or peptide is combined with a sm

Neuroendocrine tumours (NETs) are heterogeneous with varying behaviour. Treatment decisions are taken basis Histological studies plus imaging data and

My last article (Which patients can benefit with PPRT?) summed up the fundamentals of Nuclear Medicine PRRT and which patients may benefit from this t

PRRT is a short form for Peptide Receptor Radionuclide Therapy. It is also known as molecular therapy or radioisotope therapy. PRRT has been found to

For advanced prostate cancer patients or metastatic castration-resistant prostate cancer (mCRPC) patients, conventional treatment modalities, such as